Newer monoclonal antibodies for hematological malignancies
- 31 July 2008
- journal article
- review article
- Published by Elsevier BV in Experimental Hematology
- Vol. 36 (7), 755-768
- https://doi.org/10.1016/j.exphem.2008.04.018
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodiesCancer and Metastasis Reviews, 2005
- Phase I/II Study of Galiximab, an Anti-CD80 Antibody, for Relapsed or Refractory Follicular LymphomaJournal of Clinical Oncology, 2005
- Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2005
- Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid LeukemiaJournal of Clinical Oncology, 2005
- Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'AdulteJournal of Clinical Oncology, 2005
- Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011Blood, 2005
- Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioningBlood, 2004
- Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemiaCancer, 2003
- A Murine Xenograft Model for Human CD30+ Anaplastic Large Cell LymphomaThe American Journal of Pathology, 1999
- CD20: a regulator of cell-cycle progression of B lymphocytesImmunology Today, 1994